 |
 |
|
U.S. Marshals Seize Paxil CR and Avandamet
On March 4, 2005, the Food and Drug Administration (FDA) and the Department of Justice seized Paxil CR and Avandamet tablets manufactured by GlaxoSmithKline, Inc. (GSK). Manufacturing practices for the two drugs, approved to treat depression and panic disorder (Paxil CR) and Type II Diabetes (Avandamet), failed to meet FDA standards that ensure product safety, strength, quality and purity. FDA is not aware of any harm to consumers by the seized products and it does not believe that these products pose a significant health hazard to consumers. FDA recommends patients to continue taking their medication, but to talk with their health care provider about possible alternatives until the manufacturing problems have been corrected. For more information, read the FDA's news release. |
 |
 |